ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2017/02/15 | 1,703 | 1,708 | 1,692 | 1,694 | +3 | +0.2% | 77,900 |
2017/02/14 | 1,703 | 1,709 | 1,691 | 1,691 | -4 | -0.2% | 108,800 |
2017/02/13 | 1,702 | 1,712 | 1,689 | 1,695 | +2 | +0.1% | 131,900 |
2017/02/10 | 1,684 | 1,704 | 1,674 | 1,693 | +22 | +1.3% | 173,600 |
2017/02/09 | 1,689 | 1,709 | 1,671 | 1,671 | -116 | -6.5% | 327,400 |
2017/02/08 | 1,790 | 1,791 | 1,761 | 1,787 | ±0 | ±0% | 75,600 |
2017/02/07 | 1,779 | 1,790 | 1,772 | 1,787 | -2 | -0.1% | 46,100 |
2017/02/06 | 1,789 | 1,789 | 1,776 | 1,789 | +12 | +0.7% | 42,400 |
2017/02/03 | 1,773 | 1,786 | 1,766 | 1,777 | +15 | +0.9% | 51,500 |
2017/02/02 | 1,772 | 1,782 | 1,752 | 1,762 | -11 | -0.6% | 64,300 |
2017/02/01 | 1,766 | 1,774 | 1,753 | 1,773 | -3 | -0.2% | 47,600 |
2017/01/31 | 1,792 | 1,795 | 1,773 | 1,776 | -31 | -1.7% | 43,800 |
2017/01/30 | 1,810 | 1,810 | 1,790 | 1,807 | -5 | -0.3% | 40,200 |
2017/01/27 | 1,810 | 1,816 | 1,798 | 1,812 | +7 | +0.4% | 90,100 |
2017/01/26 | 1,776 | 1,805 | 1,766 | 1,805 | +43 | +2.4% | 75,000 |
2017/01/25 | 1,769 | 1,770 | 1,745 | 1,762 | +20 | +1.1% | 60,200 |
2017/01/24 | 1,740 | 1,749 | 1,732 | 1,742 | -6 | -0.3% | 54,100 |
2017/01/23 | 1,769 | 1,769 | 1,745 | 1,748 | -36 | -2% | 54,500 |
2017/01/20 | 1,780 | 1,791 | 1,758 | 1,784 | +3 | +0.2% | 69,600 |
2017/01/19 | 1,775 | 1,793 | 1,763 | 1,781 | +24 | +1.4% | 92,300 |
2017/01/18 | 1,760 | 1,768 | 1,739 | 1,757 | -4 | -0.2% | 63,600 |
2017/01/17 | 1,773 | 1,774 | 1,754 | 1,761 | -21 | -1.2% | 68,800 |
2017/01/16 | 1,796 | 1,800 | 1,767 | 1,782 | -14 | -0.8% | 61,800 |
2017/01/13 | 1,779 | 1,798 | 1,776 | 1,796 | +19 | +1.1% | 60,300 |
2017/01/12 | 1,805 | 1,809 | 1,775 | 1,777 | -46 | -2.5% | 80,400 |
2017/01/11 | 1,852 | 1,852 | 1,817 | 1,823 | -12 | -0.7% | 53,400 |
2017/01/10 | 1,831 | 1,852 | 1,822 | 1,835 | +6 | +0.3% | 89,800 |
2017/01/06 | 1,831 | 1,834 | 1,816 | 1,829 | +4 | +0.2% | 64,000 |
2017/01/05 | 1,820 | 1,828 | 1,810 | 1,825 | +13 | +0.7% | 72,700 |
2017/01/04 | 1,818 | 1,825 | 1,806 | 1,812 | +8 | +0.4% | 91,200 |
2016/12/30 | 1,798 | 1,809 | 1,775 | 1,804 | +27 | +1.5% | 97,100 |
2016/12/29 | 1,786 | 1,786 | 1,763 | 1,777 | -12 | -0.7% | 72,800 |
2016/12/28 | 1,756 | 1,794 | 1,755 | 1,789 | +46 | +2.6% | 77,200 |
2016/12/27 | 1,776 | 1,790 | 1,738 | 1,743 | -37 | -2.1% | 175,800 |
2016/12/26 | 1,773 | 1,785 | 1,771 | 1,780 | +12 | +0.7% | 73,100 |
2016/12/22 | 1,774 | 1,774 | 1,756 | 1,768 | -6 | -0.3% | 97,000 |
2016/12/21 | 1,824 | 1,826 | 1,767 | 1,774 | -53 | -2.9% | 173,400 |
2016/12/20 | 1,837 | 1,838 | 1,819 | 1,827 | -11 | -0.6% | 77,200 |
2016/12/19 | 1,805 | 1,839 | 1,805 | 1,838 | +33 | +1.8% | 82,900 |
2016/12/16 | 1,805 | 1,815 | 1,801 | 1,805 | +4 | +0.2% | 118,500 |
2016/12/15 | 1,825 | 1,844 | 1,797 | 1,801 | -8 | -0.4% | 154,700 |
2016/12/14 | 1,870 | 1,870 | 1,807 | 1,809 | -56 | -3% | 140,900 |
2016/12/13 | 1,845 | 1,870 | 1,841 | 1,865 | +33 | +1.8% | 105,900 |
2016/12/12 | 1,801 | 1,844 | 1,782 | 1,832 | +37 | +2.1% | 123,900 |
2016/12/09 | 1,782 | 1,797 | 1,758 | 1,795 | +32 | +1.8% | 111,400 |
2016/12/08 | 1,799 | 1,799 | 1,752 | 1,763 | -16 | -0.9% | 81,800 |
2016/12/07 | 1,785 | 1,788 | 1,768 | 1,779 | +18 | +1% | 67,600 |
2016/12/06 | 1,794 | 1,800 | 1,750 | 1,761 | -32 | -1.8% | 109,700 |
2016/12/05 | 1,793 | 1,815 | 1,785 | 1,793 | -5 | -0.3% | 44,500 |
2016/12/02 | 1,821 | 1,831 | 1,729 | 1,798 | -35 | -1.9% | 101,300 |
1901~
1950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 225,500円 | +13.6% | +29.2% | 2.04% | 11.70倍 | 1.13倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 474,500円 | +12.0% | +28.1% | 2.53% | 26.16倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 333,500円 | +3.0% | +27.5% | 2.40% | 21.12倍 | 0.92倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 113,700円 | +197.7% | - | 0.00% | 46.46倍 | 1.49倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム